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Purpose: To investigate the effects of transcorneal electrical stimulation (TES) on eyes that 
have a branch retinal artery occlusion (BRAO).
Subjects and method: We studied two eyes having a BRAO, with an interval between the 
onset of symptoms and the beginning of treatment of .16 weeks (longstanding cases), and in 
three eyes with an interval of ,16 weeks (fresh cases). The visual functions of the eyes were 
assessed by the best-corrected visual acuity (BCVA), multifocal electroretinograms (mfERGs), 
and automated static perimetry with the Humphrey field analyzer (HFA). The mfERGs were 
recorded before and 1 month after the TES, and perimetry with the HFA was done before and 
at 1 and 3 months after the TES. The amplitudes and implicit times of the N1, P1, and N2 
components of the mfERGs were analyzed.
Results: TES did not alter the BCVA significantly in all eyes, but it led to a significant increase 
in the amplitude of the N2 wave of the mfERGs (P , 0.01). The amplitude of the N1-P1 was 
also increased but not significantly. The implicit times of N1 (P , 0.01) and P1 (P , 0.05) were 
significantly shorter than that before the TES. The mean deviation of the HFA was increased 
after the TES but only in the longstanding cases.
Conclusion: Our results indicate that TES improves the visual function in eyes with BRAO, 
mainly in longstanding cases.
Keywords: BRAO, TES, multifocal electroretinogram (mERG), automated static visual field
Introduction
Retinal artery occlusions (RAOs) usually lead to permanent retinal damage and 
a decrease of vision. There are two types of RAOs with very different clinical 
features: the central retinal artery occlusion (CRAO) and the branch retinal artery 
occlusion (BRAO). A CRAO results in a severe decrease of visual function due to 
the decrease or blockage of retinal blood flow to the macula. If anticoagulant or 
vasodilator therapy is not initiated rapidly, visual prognosis is poor. In contrast, a 
BRAO leads to visual field defects corresponding to the ischemic retinal areas, and if 
the BRAO does not involve the fovea, the patient has relatively good vision. Hayreh 
et al reported that even if a case had a visual acuity ,20/40 at the initial   examination, 
79% of these cases can have an improvement of their visual acuity.1 However, the 
decrease in the visual functions of both types is permanent unless the treatment starts 
soon after the occlusion.
Transcorneal electrical stimulation (TES) is a relatively noninvasive method of 
activating the retina electrically. Experiments on animal models have shown that TES 
protects the retinal ganglion cells (RGCs) and photoreceptors from   degeneration, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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  possibly by upregulating certain bioactive factors; for 
example, IGF-1 (insulin-like growth factor-1), BDNF (brain 
derived neurotrophic factor), CNTF (ciliary neurotrophic 
factor), and Bcl-2 (B-cell lymphoma 2).2–8 In addition, TES 
has been shown to improve the visual function in patients 
with traumatic optic neuropathy, anterior ischemic optic 
neuropathy,9 and RAOs10 with only minor complications. 
Thus, there is some evidence that TES improves visual 
function including visual field defects and multifocal elec-
troretinograms (mfERGs) in longstanding cases of CRAO 
and BRAO, although the number of cases is still small. 
This suggested that TES may improve the retinal function 
even in cases of long duration (longstanding cases). But it 
has not been determined whether TES will be effective on 
fresh cases of RAOs which might be more effective than 
longstanding cases.
Thus, the purpose of this study was to determine whether 
TES improves the visual function of three fresh cases of 
BRAO and two cases of longstanding BRAO. Static perim-
etry and mfERG were used to assess visual function before 
and after the TES.
Patients and methods
TES was performed on five cases of BRAO, and all had 
best-corrected visual acuity (BCVA) of $1.0 decimal 
  acuity. The clinical features of each case are summarized 
in Table 1. The protocol used was approved by Institutional 
Review Board of the Hyogo College of Medicine. The 
procedures conformed to the tenets of the Declaration of 
Helsinki, and an informed consent was obtained from all 
participants after an   explanation of the procedures.
The cases were divided into two groups based on the 
interval between the onset of the symptoms and the begin-
ning of TES. The cases with an interval ,16 weeks were 
defined as fresh cases, because retinal infarcts are resolved 
by 6 weeks in 80% of the BRAO cases, and optic disc pal-
lor does not appear before 13.6 weeks in 33% patients.1 
The cases with an interval of .16 weeks were defined as 
longstanding cases.
TES was performed as in previous reports.9,11–13 
The   cornea was anesthetized with 0.4% oxybuprocaine 
  hydrochloride and covered with 3% hyaluronic acid and 
4%   chondroitin sulfate (Viscot Alcon Japan Tokyo Japan). 
A bipolar Burian-Allen contact lens electrode (Hansen 
Ophthalmic Laboratories, Iowa, IA, USA) was placed 
on the cornea. Electric current pulses were delivered from 
an electronic pulse generator (Nihon Koden, Tokyo, Japan) 
through a stimulus isolation unit (WPI, Sarasota, FL, USA) 
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Changes in multifocal erG after transcorneal electrical stimulation
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Figure 1 The representative mferGs before and after Tes and mferGs are divided 
into two response groups are shown. The representative changes of the mferGs 
before (A) and after (B) three sessions of Tes. After Tes, the mferGs in the affected 
area are improved (red line). The all trace arrays are divided into two groups (C); 
the affected areas (red boxes) and unaffected areas (brown boxes) by the horizontal 
line. The amplitudes of N1-P1 and N2 in the affected and unaffected areas were 
measured, and the ratio of the sum of the affected areas and of the unaffected areas 
were calculated. in the same way, we summed the implicit times of N1, P1, or N2 in 
each area and calculated the ratio of affected area and unaffected area. The fundus 
photographs before (D) and after (E) Tes in the fresh case (No. 4 case in Table 1). 
The retinal opacity was found in the lower macular area before Tes (D). Twenty-
four months after Tes, the retinal degeneration appeared corresponding to the 
ischemic lesion, but any other retinal changes did not occur.
Abbreviations: mfERGs, multifocal electroretinograms; TES, transcorneal electrical 
stimulation.
to the two concentric electrodes embedded in the contact lens. 
The threshold current to elicit phosphenes was determined 
by increasing the current intensity from 0 to 1000 µA. The 
currents were biphasic pulses at 20 Hz, and the duration of 
each TES session was 30 minutes. The intensity to elicit 
a phosphene ranged between 500 and 900 µA, and the 
  phosphene was perceived in both the peripheral and central 
visual fields.
The mfERGs were recorded from the affected eye with 
the Visual Evoked Response Imaging system (VERIS)® 
before and 1 month after the TES following the International 
Society for Clinical Electrophysiology of Vision (ISCEV) 
guidelines.14,15 The central 50 degrees of the fundus was 
stimulated by an array of 61 hexagonal stimuli that were dis-
played on a monochromatic monitor. The luminance of each 
hexagon was alternated between black and white according 
to a pseudorandom binary m-sequence at a rate of 75 Hz. 
An X-shaped fixation target was displayed at the center 
of the monitor, and the fixation was carefully monitored 
during the recordings. The best refractive correction for 
the target distance was worn during the recordings. The 
recording   sessions were divided into eight approximately 
equal   segments. The signals were amplified 105 times, and 
the band pass filters were set at 10 and 300 Hz. The data were 
analyzed using the VERIS Science 4.1.1 analysis program 
(Electro Diagnostic Imaging, Redwood City, CA, USA). 
The initial negative wave was designated as N1, the follow-
ing positive wave was designated as P1, and the following 
negative wave was designated as N2. The implicit time 
of N1, P1, and N2 was taken to be the time from stimulus 
onset to the peak of N1, P1, and N2, and the amplitude was 
assessed as the peak-to-peak amplitude of N1 and P1. The 
amplitude of N2 was assessed as the amplitude of the N2 
peak measured from the baseline (Figures 1A and 1B). The 
mfERGs were grouped into the unaffected and affected areas 
along the horizontal midline (Figure 1C). The sum of ampli-
tudes of N1–P1 or N2 waves in each area was calculated, 
and the ratio of the affected area to the unaffected area was 
calculated. Similarly, the ratios of the implicit times of P1, 
N1 and N2, and N2 for the affected and unaffected areas 
were calculated.
Automated static perimetry was performed under full 
correction of the refractive error using the Humphrey field 
analyzer (HFA) central 30-2 program. Visual fields were 
obtained before, and 1 and 3 months after TES, and only 
reliable data that had ,20% fixation errors, ,33% false 
positives, and ,33% false negatives were used in the 
analyses.
The statistical analyses were performed by paired t-tests 
between the pre-TES and one of the three post-TES values. 
Differences in the two values were taken to be significant 
when P was , 0.05.
Results
There were three men and two women whose average age 
was 69 ± 3.6 (±standard deviation) years. The average 
interval between the onset of the visual symptoms and the 
beginning of the TES was 24 ± 33 weeks. Two of the eyes 
had an interval of .16 weeks, and the other three cases had 
an interval ,16 weeks (Table 1).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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After the TES, the fundus in all cases was normal   without 
signs of degeneration (Figures 1D and 1E). The BCVA 
did not decrease significantly in any of the cases after the 
TES (data not shown). All longstanding cases had a .3 dB 
increase in the mean deviation of the visual fields after TES 
(Figures 2A and 2B; Table 1). On the other hand, the mean 
deviation did not increase in the three fresh cases (Figures 2C 
and 2D; Table 1).
The results of earlier studies of TES on longstanding cases 
of BRAO and CRAO showed that TES improved the visual 
field defects determined by kinetic perimetry and mfERGs in 
cases that had an interval of .6 months before the beginning 
of TES.10 We were able to record the mfERGs with good 
fixation, and our results showed that the amplitudes of all 
components were increased and the implicit times reduced 
(Figure 3). Among these improvements, the relative N2 
amplitude was significantly increased (pre-TES, 0.49 and 
post-TES, 0.75, P = 0.007, paired t-tests; Figures 1 and 3A). 
The ratio of the implicit times of N1 and P1 before TES were 
1.15 and 1.13, respectively, and the ratios were 1.02 and 1.01, 
respectively, after the TES. These values were significant 
different from the pre-TES (P = 0.002, P = 0.01, paired 
t-tests). The ratio of implicit time of N2 was very slightly 
reduced, but the reduction was not significant   (pre-TES 1.19 
and post-TES 1.15, P = 0.15, paired t-test).
Discussion
Our results showed that TES led to a significant increase in 
the amplitude of the N2 wave of the mfERGs (P , 0.01), 
and the amplitude of the N1-P1 was also increased but not 
significantly. The implicit times of N1 (P , 0.01) and P1 
(P , 0.05) were significantly shorter than before the TES. 
The mean deviation of the HFA was increased after the TES 
in the longstanding cases but not fresh cases.
Hasegawa et al demonstrated that the amplitudes of the 
N1 and P1 components of the mfERGs in eyes with a BRAO 
were reduced.16 Experimental studies on rhesus monkeys 
showed that more than 105 minutes of clamping of the 
central retinal artery induced irreversible retinal damage in 
the nerve fiber layer, retinal ganglion cell layer, inner plexi-
form layer, and the inner nuclear layer.17 Pharmacological 
studies on rhesus monkeys showed that N1 is reduced after 
AB
CD
Figure 2 Change of visual fields after TES. (A, B) Visual fields of Case 2. Change 
of visual fields in a longstanding case before (A) and one month after (B) Tes. The 
superior visual field defect is decreased. (C, D) Visual fields of Case 3. The change 
of the visual field in a fresh case before (C) and one month after (D) Tes. The visual 
field defect is unchanged after TES.
Abbreviation: Tes, transcorneal electrical stimulation.
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Figure  3  The  ratio  of  an  affected  and  unaffected  area  of  each  multifocal 
electroretinogram components. A) ratio of N1-P1 and N2 amplitude before and 
1 month after Tes. N1-P1 and N2 amplitudes are increased after Tes, N2 amplitude 
was significant (P , 0.05, paired t-test). B) ratio of implicit times of N1, P1, and 
N2 before and 1 month after Tes. N1 and P1 implicit times were decreased in 
comparison to the level of pre-TES. N1 and P1 had a significant decrease in the 
implicit times (P , 0.01 and P , 0.05, respectively).
Notes:  **increase  or  †  and  ††  decrease  was  different  from  pre-Tes  group  at 
P , 0.01 and P , 0.01 compared with pre-Tes, paired t-tests.
Abbreviation: Tes, transcorneal electrical stimulation.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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intravitreous injection of cis-2,3 piperidine dicarboxylic acid 
(PDA), a glutamate analog that blocks the transmission from 
photoreceptors to OFF-bipolar cells. P1 is suppressed by 
2-amino-4 phosphonobutyric acid (APB), a selective blocker 
of the synaptic transmission from photoreceptors to the ON-
bipolar cells of the ON response pathway.18,19
These findings suggest that neurons in both the inner 
and outer retina contribute to the amplitudes of N1 and P1. 
From this, it is reasonable to suggest that the alterations of 
the mfERGs in eyes with a BRAO reflect damage of the 
inner and outer retina.
Experimental studies on a chronic glaucoma model 
induced by laser irradiation of the anterior chamber 
angle showed that N2 was reduced more than P1 and N1 
  suggesting that the N2 component originated mainly from 
the RGC layer.18 Our results showed that the amplitudes and 
implicit times of all components of the mfERGs, except the 
implicit time of N2, were improved after TES. Thus, our data 
suggest that TES had beneficial effects on both the inner and 
outer retina after BRAO, as was reported in animal experi-
ments, although it still has not been determined whether TES 
will affect the retinal thickness.17
Inomata et al demonstrated that monthly TES improved 
visual field defects and mfERGs in eyes with CRAO and 
BRAO that had .15 months interval between the onset 
of symptoms and the beginning of TES therapy.10 Our 
results showed that the mean deviation of the HFA and the 
components of mfERGs of longstanding cases improved, 
although the visual field of fresh cases did not improve. 
These findings were not expected, as we expected that fresh 
cases would improve while the longstanding cases would 
not improve. One possibility for this difference is that our 
cases may include cases whose retinal vessels re-canalized 
soon or whose degree of occlusion was partial, so that retinal 
function could still recover after the resolution of the retinal 
edema. However, we studied only three fresh cases and two 
longstanding cases in the present study. Thus, more cases 
are needed to confirm the difference of TES effects between 
fresh and longstanding cases.
It has been reported that TES increases the chorioretinal 
blood flow in normal individuals, which may contribute to the 
improvement of visual function in cases with BRAO.13 The 
exact mechanism of how TES improves retinal function still 
remains undetermined, and further investigations are needed 
to determine whether TES preserves the retinal thickness after 
arterial occlusion. It must also be determined whether TES 
affects fresh and longstanding cases with RAOs differently.
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